Long-term benefits of immunoadsorption in β1-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy

European Journal of Heart Failure

Volumn 14, Issue 12, 2012, Pages 1374-1388

  Dandel, Michael ^a   Wallukat, Gerd ^b   Englert, Angela ^a   Lehmkuhl, Hans B ^a   Knosalla, Christoph ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

1 receptors; Autoantibodies; Dilated cardiomyopathy; Heart failure; Immunoadsorption; Survival

Indexed keywords

AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR AUTOANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; IMMUNOADSORPTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; VENTRICULAR ASSIST DEVICE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; CASE-CONTROL STUDIES; DIGOXIN; DIURETICS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ADRENERGIC, BETA-1; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 84870433700     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs123     Document Type: Article

References (34)

1. Gerli R, Rambotti P, Spinozzi F., Bertotto A, Chiodini V, Solinas P, Gernini I, Davis S. Immunologic studies of peripheral blood from patients with idiopathic dilated cardio-myopathy. Am Heart J 1986;112:350-355.
2. Schulze K, Becker BF, Schauer R., Schultheiss HP. Antibodies to ADP-ATP carrier-an autoantigen in myocarditis and dilated cardiomyopathy-impair cardiac function. Circulation 1990;81:959-969.
3. Wallukat G, Wollenberger A. Effects of serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic b-adrenergic function in cultured rat heart myocytes. Biomed Biochim Acta 1987;78:634-639.
4. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against beta-1-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989;64:97-103.
5. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the beta-1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89:2760-2767.
6. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF. Anti-beta-1-adrenoceptor antibodies with chronotropic activity from serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 1995:27:397-394.
7. Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardio-myopathy and myocarditis: pathogenic and clinical significance. Eur J Heart Fail 2002:4:411-417.
8. Fu LX, Magnusson Y, Bergh CH, Liljeqvist JA, Waagstein F, Hjalmarson A, Hoebeke J. Location of functional autoimmune epitopes on muscarinic acetylcho-line receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993;91:1964-1968.
9. Wallukat G, Reinke P, Dörffel WV., Luther HP, Bestvater K, Felix SB, Baumann G. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 1996;54:191-195.
10. Müller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000;101:385-391.
11. Dörffel WF, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P. Short term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997;95:1994-1997.
12. Matsui S, Fu ML, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmarson A. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997;29:641-655.
13. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ. Direct evidence for beta-1 adrenergic receptor-directed auto-immune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004;113:1419-1429.
14. Felix SB, Staudt A, Dörffel WV, Stangl V, Merkel K, Pohl M, Döcke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three month results from a randomized study. J Am Coll Cardiol 2000;35:1590-1598.
15. Knebel F, Böhm M, Staudt A, Borges AC, Tepper M, Jochmann N, Wernicke KD, Felix S, Baumann G. Reduction of morbidity by immunadsorption therapy in patients with dilated cardiomyopathy. Int J Cardiol 2004;97:517-520.
16. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human beta adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-654.
17. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S. Autoantibodies against the second extracellular loop of b1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyop-athy. J Am Coll Cardiol 2001;37:418-424.
18. Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002; 39:646-652.
19. Wallukat G, Müller J, Hetzer R. Specific removal of beta-1-adrenergic autoanti-bodies from patients with dilated cardiomyopathy. N Engl J Med 2002;347:1806.
20. Wallukat, Muñoz Saravia SG, Haberland A, Bartel S, Araujo R, Valda G, Duchen D, Diaz Ramirez I, Borges AC, Schimke I. Distinct patterns of autoanti-bodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. J Am Coll Cardiol 2010;55:463-468.
21. Wallukat G, Müller J, Podlowski S, Nissen E, Morwinski R, Hetzer R. Agonist like beta-adrenergic antibodies in heart failure. Am J Cardiol 1999;83:75H-79H.
22. Staudt Y, Mobini R, Fu M, Felix SB, Kühn JP, Staudt A. Beta-1-adrenoceptor auto-antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 2003;466:1-6.
23. Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R. Stimulating auto-antibodies directed against beta-1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 2006;152:697-704.
24. Mobini R, Magnusson Y, Wallukat G, Viguier M, Hjalmarson A, Hoebeke J. Probing the immunological properties of the extracellular domains of the human b1-adrenoceptor. J Autoimmun 1999;13:179-186.
25. Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, Knosalla C, Hetzer R. Prediction of cardiac stability after weaning from ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 2008; 118[suppl 1]:S94-S105.
26. Staudt A, Dorr M, Staudt Y, Böhm M, Probst M, Empen K, Plötz S, Maschke HE, Hummel A, Baumann G, Felix SB. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J 2005; 150:729-736.
27. Staudt A, Hummel A, Ruppert J, Dörr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix SB. Immunoadsorbtion in dilated cardiomyopahy: 6 months results from a randomized study. Am Heart J 2006;152:712.el-6.
28. Schimke I, Müller J, Priem F, Kruse I, Schön B, Stein J, Kunze R, Wallukat G, Hetzer R. Decreased oxidative stress in patients with idiopathic dilated cardiomy-opathy: one year after immunoglobulin adsorption. J Am Coll Cardiol 2001; 38:178-183.
29. Mobini R, Staudt A, Felix SB, Baumann G, Wallukat G, Deinum J, Svensson H, Hjalmarson A, Fu M. Hemodynamic improvement and removal of auto-antibodies against beta-1 adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003;20:345-350.
30. Dörffel WV, Wallukat G, Dörfel Y, Felix SB, Baumann G. Immunoadsorption in dilated cardiomyopathy, a 3 year follow-up. Int J Cardiol 2004;97529-534.
31. Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Kucheryavaya AY, Rahmel AO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Tansplant 2009;28:1007-1022.
32. Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, Goeser S, Kaya Z, Koch A, Zugck C, Katus HA. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Basic Res Cardiol 2011;106:25-35.
33. Rönspeck W, Brinckmann R, Egner R, Gebauer F, Winkler D, Jekow P, Wallukat G, Müller J, Kunze R. Peptide based adsorbers for therapeutic immunoadsorption. Ther Apher Dial 2003;7:91-97.
34. Deubner N, Berliner D, Schlipp A, Gelbrich G, Caforio AL, Felix SB, Fu M, Katus H, Angermann CE, Lohse MJ, Ertl G, Störk S, Jahns R; Etiology, Titre-Course, and Survival-Study Group. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study. Eur J Heart Fail 2010;12:753-762.